Back to Journals » Drug, Healthcare and Patient Safety » Volume 6

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin

Authors DaCosta J, Younis S

Received 1 October 2014

Accepted for publication 23 October 2014

Published 25 November 2014 Volume 2014:6 Pages 175—178


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Professor Shu-Feng Zhou

Joanna DaCosta,1,2 Saad Younis1

1The Western Eye Hospital, Imperial College Healthcare National Health Service Trust, London, United Kingdom; 2Barts Health National Health Service Trust, St Bartholomew's Hospital, West Smithfield, London, United Kingdom

Abstract: Vitreomacular traction and vitreomacular traction with macular hole are conditions associated with visual disturbance and decreased visual acuity. Recent studies have demonstrated that ocriplasmin is effective and safe in specific patient groups with vitreomacular traction, and hence is recommended as a treatment option. We present here a case report of a patient treated with intravitreal ocriplasmin associated with severe loss of vision and delayed resolution of vitreomacular traction. This report highlights that it is important for patients to be made fully aware of the risks of intravitreal ocriplasmin and the prognosis for visual improvement.

Keywords: ocriplasmin, macular hole, visual loss, vitreoretinal

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]